Quantifying Patellar Tendon Microstructure Using DTI

NCT ID: NCT06381492

Last Updated: 2026-01-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

62 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-05-21

Study Completion Date

2025-12-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this observational study is to understand how diffusion tensor imaging (DTI) relates to other traditional measures and knee function. The main question it aims to answer is:

Will regions of known patellar tendon pathology present with smaller DTI scalar parameters, shorter fiber length, and lower fiber density compared to the contralateral tendon and healthy regions in the ipsilateral tendon.

Participants will:

* undergo MRI and ultrasound imaging
* perform knee function test
* complete questionnaires

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patellar tendon injuries are commonly accompanied by macrostructural alterations captured on common imaging modalities, and the extent of these alterations correlate to knee joint function. Evidence for using tendon macrostructure for diagnosis and prognosis of tendon injuries is not as clear, suggesting that these imaging modalities are not providing a complete picture of the alterations. Diffusion tensor imaging (DTI) tractography can quantify tendon microstructures that underlie the alterations in pathological tendons and shows promising results in healthy tendons. This study is the first step in evaluating whether tendon microstructure captured using DTI technology can be applied as a biomarker to optimize treatment for patellar tendon injuries.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Patellar Tendinopathy Anterior Cruciate Ligament Reconstruction

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Bone-patellar tendon-bone (BPTB)

This group will have patellar injury confirmed through self-reported surgical history and evidence of ipsilateral BPTB graft harvest on ultrasound.

MRI

Intervention Type DEVICE

MRI using DTI technology

Ultrasound (US)

Intervention Type DEVICE

Standard US

Neuromuscular electric stimulation (NMES)

Intervention Type DEVICE

Standard NMES

Patellar tendinopathy group

This group will have patellar tendinopathy confirmed based on International Scientific Tendinopathy Symposium Consensus on Clinical Terminology (ICON) statement, which defines patellar tendinopathy as "persistent patellar tendon pain and loss of function related to mechanical loading." Ultrasound diagnosis must confirm alteration of tendon macrostructure.

MRI

Intervention Type DEVICE

MRI using DTI technology

Ultrasound (US)

Intervention Type DEVICE

Standard US

Neuromuscular electric stimulation (NMES)

Intervention Type DEVICE

Standard NMES

Healthy knees

Control group of participants with healthy knees

MRI

Intervention Type DEVICE

MRI using DTI technology

Ultrasound (US)

Intervention Type DEVICE

Standard US

Neuromuscular electric stimulation (NMES)

Intervention Type DEVICE

Standard NMES

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MRI

MRI using DTI technology

Intervention Type DEVICE

Ultrasound (US)

Standard US

Intervention Type DEVICE

Neuromuscular electric stimulation (NMES)

Standard NMES

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18 or older
* Have patellar tendon injury as confirmed through subjective report, clinical examination, and ultrasound by an experienced physical therapist
* Patellar tendinopathy group must present with current symptoms of patellar tendinopathy
* Control group must have no history of patellar tendon injury

Exclusion Criteria

* Participants with a history of invasive procedures other than bone-patellar tendon-bone (BPTB) autograft harvest to the patellar tendon or extensor mechanism
* Participants with history of contralateral BPTB autograft harvest, or ACLR using any other graft type
* Participants with contraindications to MRI
* Participants with contraindications to NMES
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

Sponsor Role collaborator

University of Wisconsin, Madison

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bryan Heiderscheit, PT, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Wisconsin, Madison

Daniel Cobian, DPT, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Wisconsin, Madison

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Wisconsin - Madison

Madison, Wisconsin, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1K99AR085752-01

Identifier Type: NIH

Identifier Source: secondary_id

View Link

A536130

Identifier Type: OTHER

Identifier Source: secondary_id

SMPH/ORTHO&REHAB/PHYS THER

Identifier Type: OTHER

Identifier Source: secondary_id

Protocol Version 10/1/2025

Identifier Type: OTHER

Identifier Source: secondary_id

2024-0057

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.